DUNCAN BARBARA GAYLE

• NEW YORK, NY How do I update this listing?

Duncan Barbara Gayle is based out of New York. Whalewisdom has at least 52 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor.

Contact Info

duncan barbara gayle
C/O INTERCEPT PHARMACEUTICALS, INC.
NEW YORK NY 10013
Business Phone: 212-776-4381

SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Insider Information

Intercept Pharmaceuticals Inc - CHIEF ACCOUNTING OFFICER (10/03/2016)
Aevi Genomic Medicine Inc - Director (02/03/2020)
Adaptimmune Therapeutics Plc ADR - Director (07/01/2022)
Innoviva Inc - Director (04/20/2017)
Jounce Therapeutics Inc - Director (06/24/2022)
Ovid Therapeutics Inc - Director (02/23/2023)
DOV Pharmaceutical Inc - CEO (05/16/2008)
Immunomedics Inc. - Director (10/23/2020)
Aviron Inc. - Director (06/18/2021)
FUSION NETWORKS HOLDINGS INC - Director (10/30/2020)
Fusion Pharmaceuticals Inc. - Director (06/14/2022)
Atea Pharmaceuticals Inc. - Director (06/17/2022)
Halozyme Therapeutics Inc - Director (02/03/2023)

DUNCAN BARBARA GAYLE

Contact Info

Insider Information

Recent SEC Filings

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Elevate your investments

DUNCAN BARBARA GAYLE

Email Notification.

Contact Info

Insider Information

Recent SEC Filings

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Elevate your investments